We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+6.47%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.29B
AUM Growth
+$160M
Cap. Flow
+$8.37M
Cap. Flow %
0.16%
Top 10 Hldgs %
23.19%
Holding
318
New
66
Increased
91
Reduced
86
Closed
36

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$80.3M
2
PFE icon
Pfizer
PFE
+$58.1M
3
HCA icon
HCA Healthcare
HCA
+$35M
4
JNJ icon
Johnson & Johnson
JNJ
+$34.9M
5
EVHC
Envision Healthcare Holdings Inc
EVHC
+$28.7M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$40.7M
2
RTX icon
RTX Corp
RTX
+$40.3M
3
ABT icon
Abbott
ABT
+$31.8M
4
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$29.2M
5
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
+$28.6M

Sector Composition

Rank Sector Weight
1 Technology 26.44%
2 Healthcare 24.73%
3 Financials 20.02%
4 Communication Services 11.49%
5 Consumer Discretionary 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCSG icon
226
Healthcare Services Group
HCSG
$1.59B
$1.23M 0.02%
38,372
– –
HDB icon
227
HDFC Bank
HDB
$123B
$1.2M 0.02%
81,520
– –
HSTO
228
DELISTED
Histogen Inc. Common Stock
HSTO
$1.11M 0.02%
783
-467
-37% -$592K
SSYS icon
229
Stratasys
SSYS
$668M
$1.08M 0.02%
20,390
-27,865
-58% -$1.85M
MODN
230
DELISTED
MODEL N, INC.
MODN
$850K 0.02%
71,266
+21,266
+43% +$244K
SGYP
231
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$846K 0.02%
+183,119
New +$595K
ACAD icon
232
Acadia Pharmaceuticals
ACAD
$4.45B
$844K 0.02%
25,898
+2,356
+10% +$81K
VIVO
233
DELISTED
Meridian Bioscience Inc
VIVO
$816K 0.02%
42,800
– –
EVOL
234
DELISTED
Evolving Systems, Inc.
EVOL
$801K 0.02%
91,973
-54,031
-37% -$475K
LAB icon
235
Standard BioTools
LAB
$321M
$786K 0.01%
18,681
-1,513
-7% -$59.8K
ALNY icon
236
Alnylam Pharmaceuticals
ALNY
$38.6B
$716K 0.01%
6,857
+487
+8% +$49.4K
RDUS
237
DELISTED
Radius Health, Inc.
RDUS
$714K 0.01%
+17,342
New +$779K
MCK icon
238
McKesson
MCK
$106B
$679K 0.01%
3,000
– –
GEVA
239
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$671K 0.01%
6,881
-3,403
-33% -$360K
AERI
240
DELISTED
Aerie Pharmaceuticals
AERI
$668K 0.01%
21,310
-4,097
-16% -$119K
RLYP
241
DELISTED
RELYPSA INC COM
RLYP
$653K 0.01%
18,110
-5,859
-24% -$211K
CLVS
242
DELISTED
Clovis Oncology, Inc.
CLVS
$646K 0.01%
+8,704
New +$615K
PCRX icon
243
Pacira BioSciences
PCRX
$1.04B
$636K 0.01%
7,153
+2,066
+41% +$210K
SIVB
244
DELISTED
SVB Financial Group
SIVB
$550K 0.01%
4,326
– –
CLDX icon
245
Celldex Therapeutics
CLDX
$2.8B
$545K 0.01%
+1,304
New +$466K
SGMO
246
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$538K 0.01%
+34,326
New +$531K
XLRN
247
DELISTED
Acceleron Pharma
XLRN
$535K 0.01%
+14,049
New +$559K
CMRX
248
DELISTED
Chimerix, Inc.
CMRX
$522K 0.01%
13,849
-8,554
-38% -$340K
PPBI
249
DELISTED
Pacific Premier Bancorp
PPBI
$504K 0.01%
31,150
+8,131
+35% +$130K
CASH icon
250
Pathward Financial
CASH
$1.88B
$498K 0.01%
37,641
+10,647
+39% +$126K
8 9
10
11 12

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q1 2015 Portfolio in Review

As of Q1 2015, Polar Capital held 318 positions worth $5.29B, up 3.1% from $5.13B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Polar Capital's Q1 2015 filing shows 66 new, 91 increased, 86 reduced and 36 closed positions. Its largest new stake was Envision Healthcare Holdings Inc: 263,860 shares worth $30.3M. The largest sale was Microsoft, an estimated $40.7M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Polar Capital's largest Q1 2015 buy was Envision Healthcare Holdings Inc: 263,860 shares worth $30.3M.
  • Polar Capital added most to Thermo Fisher Scientific in Q1 2015, an estimated $80.3M increase.
  • Polar Capital's biggest Q1 2015 reduction was Microsoft, cutting an estimated $40.7M.
  • Polar Capital fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $29.2M.
  • Polar Capital's ten largest holdings make up 23% of its $5.29B portfolio in Q1 2015.
  • Polar Capital opened 66 new positions and closed 36 in Q1 2015.
  • Polar Capital's portfolio value rose 3.1% quarter-over-quarter to $5.29B.

Based on Polar Capital's 13F filing for Q1 2015, filed 15 May 2015.